XELODA 150 (Xeloda 150 mg)

Generic Name: capecitabine

Pill imprint XELODA 150 has been identified as Xeloda 150 mg.

Xeloda is used in the treatment of colorectal cancer; breast cancer, metastatic; pancreatic cancer; breast cancer; stomach cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for XELODA 150 (Xeloda 150 mg)

Xeloda 150 mg XELODA 150
Xeloda 150 mg XELODA 150
Xeloda 150 mg XELODA 150
Xeloda
Generic Name:
capecitabine
Imprint:
XELODA
150
Strength:
150 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-1100
Inactive Ingredients:
croscarmellose sodium
hypromellose 2208 (15000 mPa.s)
microcrystalline cellulose
magnesium stearate
water
magnesium silicate
titanium dioxide
ferric oxide red
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4143 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web1)